00907.HK
Elegance Optical International Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · HK
HKD 0.06
−1.61%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 82.8M | 14.5M | 24.0M | 21.7M | 15.3M |
| Cost of Revenue | 60.2M | 13.4M | 19.1M | 15.3M | 64.2M |
| Gross Profit | 22.7M | 1.0M | 4.9M | 6.4M | (48.9M) |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 38.6M | 17.7M | 22.1M | 14.9M | 71.6M |
| General & Admin Expense | 26.5M | 17.5M | 22.0M | 14.7M | 17.1M |
| Selling & Marketing Expense | 336.0K | 228.0K | 128.0K | 255.0K | 54.6M |
| Other Expenses | — | 400.0K | — | 57.0K | 60.0K |
| Total Operating Expenses | 38.6M | 18.1M | 23.9M | 31.1M | 30.1M |
| Cost and Expenses | 98.8M | 31.5M | 43.0M | 46.4M | 94.3M |
| Operating Income (EBIT) | (16.0M) | (17.0M) | (17.2M) | (24.7M) | (79.0M) |
| Non-Operating | |||||
| Interest Income | 34.0K | 20.0K | 15.0K | — | 1.0K |
| Interest Expense | 4.3M | 2.9M | 599.0K | 452.0K | 1.1M |
| Net Interest Income | (4.2M) | (2.8M) | (584.0K) | (452.0K) | (1.1M) |
| Other Non-Op Income/Expense | (60.4M) | (18.5M) | (42.1M) | (26.6M) | (97.3M) |
| Non-Operating Income (excl Interest) | 34.0M | 15.6M | 41.5M | 26.9M | 96.2M |
| EBT (Pre-Tax Income) | (76.3M) | (35.5M) | (59.4M) | (36.1M) | (169.7M) |
| Income Tax Expense | (15.3M) | (15.3M) | — | 48.7M | 44.0K |
| Bottom Line | |||||
| Net Income | (61.0M) | (20.2M) | (59.4M) | (84.8M) | (177.1M) |
| Earnings from Cont. Ops | (61.0M) | (20.2M) | (59.4M) | (36.8M) | (176.4M) |
| Earnings from Discont. Ops | — | — | — | (8.8M) | (5.8M) |
| Bottom Line Net Income | (61.0M) | (20.2M) | (59.4M) | (77.4M) | (177.1M) |
| Per Share | |||||
| Basic EPS | (HK$0.07) | (HK$0.02) | (HK$0.07) | (HK$0.10) | (HK$0.20) |
| Diluted EPS | (HK$0.07) | (HK$0.02) | (HK$0.07) | (HK$0.10) | (HK$0.20) |
| Revenue Per Share | HK$0.09 | HK$0.02 | HK$0.03 | HK$0.02 | HK$0.02 |
| Shares | |||||
| Basic Shares Outstanding | 872.9M | 872.9M | 872.9M | 872.9M | 872.9M |
| Diluted Shares Outstanding | 872.9M | 872.9M | 872.9M | 872.9M | 872.9M |
| Profitability Metrics | |||||
| EBITDA | (45.0M) | (28.3M) | (53.8M) | (33.1M) | (170.6M) |
| D&A | 9.1M | 4.4M | 4.9M | 2.5M | 4.6M |
| EBIT | (49.9M) | (32.7M) | (58.8M) | (36.4M) | (175.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2025